Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 168 results found. Search for [ Bayer ]

Results 140 to 160 of 168
E Kumar Sharma
Hyderabad, May 4, 2012
Cipla says that its decision to slash prices of cancer drugs is purely a humanitarian gesture. In cancer treatment, it is planning to do what it did in anti-AIDS drugs many years ago by launching them at low prices.

New Delhi, May 3, 2012
Cipla Chairman and MD YK Hamied said, \"This initiative of price reduction is a humanitarian approach by Cipla to support cancer patients.\"

Associated Press
New York, April 18, 2012
Nestle is one of the world's largest sellers of infant formula and may face some antitrust hurdles to complete the deal, according to a report in The Wall Street Journal.

Suman Layak and Geetanjali Shukla
April 12, 2012
Harsh Goenka, chairman, RPG Enterprises, in a free-wheeling, nearly two-hour-long, chat with Business Today's Suman Layak and Geetanjali Shukla discusses his companies' overseas plans.

Dinesh C. Sharma
New Delhi, March 28, 2012
The landmark decision of the patent office to break the monopoly of Bayer in kidney and liver cancer drugs recently is already having a rippling effect.

E. Kumar Sharma
March 27, 2012
Compulsory licences have brought domestic and multinational pharma companies face to face. Although domestic firms are getting to make cheaper versions of patented drugs, will this be enough to cure the country of its health care ills?

E Kumar Sharma
March 13, 2012
This is the first time an Indian company has been granted a compulsory licence, which means the patent holders grant licences to generic drug makers.

N. Madhavan
November 28, 2011
The formerly slow moving agrochemicals sector is suddenly booming. Apart from farm labour shortage, several other developments are fuelling the increasing use of agrochemicals. Crucially, farmers are becoming more aware of their benefits.

Mumbai, April 11, 2011
Amid news that the company is likely to enter into a marketing tie up with US drug major Merck & Co, Sun Pharma's shares jumped to touch Rs 455.90 on BSE.

Mumbai, April 1, 2011
The company, which is engaged in the agrochemicals business, rose by 8.98 per cent to an early peak of Rs 999 on the BSE.

R Shree Ram
January 5, 2011
Experts list out the companies that are likely to do well this year and the reasons you would do well to pick them up.Will commodities beat stocks this year?Post Comment

Tanvi Varma
November 10, 2010
Small- and mid-cap funds have been outperformers in the past one year, but this should not make them the mainstay of your fund portfolio.

Tanvi Varma/Money Today
December 20, 2010
Small- and mid-cap funds have been outperformers in the past one year, but this should not make them the mainstay of your fund portfolio.
October 9, 2010
Here is a look at people, places and products doing the rounds these days.
March 23, 2010
Money Today reached out to equity analysts and fund managers to know which stocks and sectors to invest in. Here's what they suggest.

R. Sree Ram
September 30, 2009
Size doesn’t matter. While blue-chip companies have performed dismally, small- and mid-caps are showing how profitable they are.

R. Sree Ram
September 24, 2009
Lalit Thakkar, Director, Research, Angel Broking tells how investors can profit by sticking to market basics and the reasons for his confidence in India’s growth story.

By Rakesh Rai
May 3, 2007
Vijay, 44, goes underwater to rake in the moolah.

Shalini S. Dagar
July 6, 2010
Two years after it slammed into a US regulatory wall, Ranbaxy Laboratories, under its Japanese owners, is working the hard way to be back among the stars.

E. Kumar Sharma
June 9, 2010
Piramal's domestic formulations business becomes the latest—and most expensive—acquisition of an Indian drug business by a global pharma major. As the stakes get higher, who's next?

PAGES 8 OF 9  6789